Risk factors, predictive markers and prevention strategies for intrauterine fetal death. An integrative review by Bohiltea, Roxana et al.
Journal of Mind and Medical Sciences 
Volume 7 Issue 1 Article 10 
2020 
Risk factors, predictive markers and prevention strategies for 
intrauterine fetal death. An integrative review 
Roxana Bohiltea 
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIA 
Natalia Turcan 
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIA 
Christina M. Cavinder 
VALPARAISO UNIVERSITY, COLLEGE OF NURSING AND HEALTH PROFESSIONS, VALPARAISO IN, USA 
Ionită Ducu 
UNIVERSITY EMERGENCY HOSPITAL BUCHAREST, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, 
BUCHAREST, ROMANIA 
Ioana Paunica 
THE NATIONAL INSTITUTE OF DIABETES, NUTRITION AND METABOLIC DISEASES “PROF. N. C. 
PAULESCU”, BUCHAREST, ROMANIA 
See next page for additional authors 
Follow this and additional works at: https://scholar.valpo.edu/jmms 
 Part of the Community Health Commons, Marriage and Family Therapy and Counseling Commons, 
Obstetrics and Gynecology Commons, and the Pharmacy and Pharmaceutical Sciences Commons 
Recommended Citation 
Bohiltea, Roxana; Turcan, Natalia; Cavinder, Christina M.; Ducu, Ionită; Paunica, Ioana; Andronache, Liliana 
Florina; and Cirstoiu, Monica Mihaela (2020) "Risk factors, predictive markers and prevention strategies 
for intrauterine fetal death. An integrative review," Journal of Mind and Medical Sciences: Vol. 7 : Iss. 1 , 
Article 10. 
DOI: 10.22543/7674.71.P5260 
Available at: https://scholar.valpo.edu/jmms/vol7/iss1/10 
This Review Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion 
in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more information, 
please contact a ValpoScholar staff member at scholar@valpo.edu. 
Risk factors, predictive markers and prevention strategies for intrauterine fetal 
death. An integrative review 
Authors 
Roxana Bohiltea, Natalia Turcan, Christina M. Cavinder, Ionită Ducu, Ioana Paunica, Liliana Florina 
Andronache, and Monica Mihaela Cirstoiu 
This review article is available in Journal of Mind and Medical Sciences: https://scholar.valpo.edu/jmms/vol7/iss1/10 
 
 Journal of Mind and Medical Sciences 
 
https://scholar.valpo.edu/jmms/  
https://proscholar.org/jmms/  
I S S N :  2 3 9 2 - 7 6 7 4  
 
 
 
To cite this article: Roxana Bohiltea, Natalia Turcan, Christina M. Cavinder, Ionită Ducu, Ioana Paunica, Liliana Florina 
Andronache, Monica Mihaela Cirstoiu. Risk factors, predictive markers and prevention strategies for intrauterine fetal death. An 
integrative review. J Mind Med Sci. 2020; 7(1): 52-60. DOI: 10.22543/7674.71.P5260  
 
Risk factors, predictive markers and prevention strategies for 
intrauterine fetal death. An integrative review 
 Roxana Bohiltea
1,2, Natalia Turcan1,2, Christina M. Cavinder3, Ionită Ducu2, Ioana 
Paunica4, Liliana Florina Andronache1, Monica Mihaela Cirstoiu1,2 
 
1
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIA  
2
UNIVERSITY EMERGENCY HOSPITAL BUCHAREST, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, BUCHAREST, ROMANIA 
3
VALPARAISO UNIVERSITY, COLLEGE OF NURSING AND HEALTH PROFESSIONS, VALPARAISO  IN, USA 
4
THE NATIONAL INSTITUTE OF DIABETES, NUTRITION AND METABOLIC DISEASES “PROF. N. C. PAULESCU”, BUCHAREST, ROMANIA 
 
 A B ST R AC T 
 
 
According to World Health Organization (WHO), fetal death is defined as the 
death of the fetus prior to its complete expulsion, independent of the duration of 
pregnancy, thus only ascribing the term stillbirth to fetal deaths in the case of 
pregnancies after 28 weeks of gestation. The great progress of perinatology care 
is reflected in a significant reduction in the rate of stillbirths, especially in well -
developed countries, with approximately 98% of stillbirth cases now occurring in 
poor and developing countries. Stillbirth powerfully impacts both the patient and 
the practitioner. Because nearly half of stillbirth cases result from apparently 
uncomplicated pregnancies, we considered it critical to review the known 
predictive markers for intrauterine fetal death. In both preterm and term infants, 
perinatal mortality is increased in fetuses small for their gestational age, and this 
risk grows proportionally with the severity of the fetal growth restriction. A 
protracted first stage of labor has not been associated with an increased risk of 
perinatal mortality and morbidity, but a prolonged second stage of labor has been 
associated with mortality and neonatal morbidity characterized by sepsis, 
seizures, and hypoxic-ischemic encephalopathy. Ultrasound examination of the 
placenta and the umbilical cord is essential for appropriate pregnancy monitoring. 
Various findings from ultrasound examination have been related to variable 
adverse perinatal outcomes, including intrauterine fetal death. After reviewing the 
evidence for predictors of intrauterine fetal death, we offer a general strategy for 
reducing the likelihood of stillbirths.   
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Introduction  
The preferred term for intrauterine fetal death, 
describing the in-utero death of a fetus after 24 weeks of 
gestation, or at least 500 grams, is stillbirth. According 
to the World Health Organization (WHO), fetal death is 
defined as the death of the fetus prior to its complete 
expulsion, independent of the duration of pregnancy, 
ascribing the term stillbirth only to fetal deaths in case 
of pregnancies after 28 weeks of gestation [1]. The limit 
between miscarriage and stillbirth varies from country 
to country, ranging between 16 and 28 weeks of 
gestation [2-4]. Conversely, stillbirth can be “early” if it 
occurs between 20 and 27 weeks of gestation and “late” 
if it complicates pregnancies with a gestational age 
higher than 28 weeks. If the gestational age is unknown, 
the second criterion that differentiates a miscarriage 
from a stillbirth is the weight and the length if the first 
two mentioned are unavailable (cut-off 25 cm).  
The great progress of perinatology is reflected in the 
significant reduction in the rate of stillbirths, especially 
in developed countries, with approximately 98% of 
stillbirth cases occurring in underdeveloped and 
developing countries [5]. A number of fetal, maternal, 
and placental factors correlate with the still birth rate, 
including black race, extreme maternal age, marital 
status, multiple gestations, and fetal sex [6,7]. 
According to McClure et al, the main factors responsible 
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are prolonged labor, preeclampsia, and infectious 
factors in developing countries, and congenital and 
various karyotype anomalies in developed countries [8].  
Stillbirth strongly impacts both the patient and the 
practitioner, especially since nearly half of stillbirths 
result from apparently uncomplicated pregnancies. 
Stillbirth that occurs in early term is more likely to have 
an obvious cause than one that occurs in late term [9-
11]. Stillbirth that cannot be explained by an obvious 
maternal, fetal, placental or obstetric factor has an 
impressive incidence of 25 to 60%, with two thirds of 
these cases occurring after 35 weeks of gestation. Given 
its relatively high rate of unpredictability, we considered 
it important to review the known predictive markers for 
intrauterine fetal death. 
Discussions 
Fetal growth restriction and intrauterine fetal 
death 
A fetus diagnosed with fetal growth restriction, 
meaning an estimated fetal weight below the 10th 
percentile for its gestational age, implies a differential 
diagnosis that distinguishes between a constitutionally 
small fetus versus growth restriction from placental, 
fetal, or maternal pathologies [12-15]. This 
differentiation is important due to the associated adverse 
perinatal outcomes, including preterm delivery, 
impaired thermoregulation, impaired immune function, 
perinatal asphyxia, hypoglycemia, diabetes, and 
mortality. According to Zeitlin et al. [9], in both preterm 
and term infants, perinatal mortality is increased in 
fetuses small for their gestational age. This risk grows 
proportionally with the severity of the fetal growth 
restriction and shows a steep rise when fetal weight is 
below the 6th percentile. In one recent study, researchers 
examined more than 1.5 million singletons’ births and 
found a significant difference in neonatal mortality 
between term infants without fetal growth restriction 
(0.6/1,000) and term infants with fetal growth restriction 
(2.8/1,000), and a larger difference between preterm 
infants with normal weight (22.9/1,000) and preterm 
infants with fetal growth restriction (60.0/1,000) [16]. 
The authors concluded that methods that can detect and 
prevent fetal growth restriction represent important 
tools in decreasing fetal mortality.  
In our unit, the Department of Obstetrics and 
Gynecology, University Emergency Hospital Bucharest, 
we conducted a retrospective study over a period of 5 
years, January 2014 – October 2018, on 1405 preterm 
infants and term infants with fetal growth restriction 
[17-20]. The overall results agree with previously cited 
results [10,21,22]. Table 1 lists the short-term 
complications encountered in the studied population, 
with the study group divided as follows: Group 1 
consists of preterm newborns small for their gestational 
age; Group 2 consists of preterm newborns appropriate 
for their gestational age; and Group 3 consists of term 
newborns small for their gestational age. 
Table 1.  The incidence of newborns in preterm and term newborns with intrauterine fetal growth restriction 
[9]. 
Characteristic 
Group 1 Group 2 Group 3 Total P value 
No. % No. % No. % No. %  
Total subjects 78 6% 1,121 80% 206 15% 1,405 100%  
Males 37 3% 573 41% 85 6% 695 49% 0.032 
Demise 14 18% 51 5% 2 1% 67 5% <0.001 
The shaded row of the table highlights the differences 
in perinatal mortality among the three groups, with the 
highest percentage corresponding to the preterm infants 
with growth restriction. No difference was found between 
term infants with fetal growth restriction and preterm 
infants with a weight appropriate for their gestational age.  
We developed a management protocol for complicated 
cases with fetal growth restriction that includesd: (1) serial 
ultrasound evaluation, biophysical profile, and Doppler 
velocimetry (from one to seven times per week) for guiding 
the subsequent pregnancy management; (2) administering 
antenatal corticosteroids for pregnancies from 24 to 34 
weeks of gestation; and (3) executing immediate delivery 
of fetuses with abnormal ductus venosus Doppler flow 
rates prior to 32 weeks  gestation,  reversed diastolic flow 
of the umbilical artery at a gestational age greater than 32 
weeks, or absent diastolic flow of the umbilical artery at 
the gestational age over 34 weeks. In order to prolong the 
duration of pregnancy over 32 weeks gestation, daily 
biophysical profiles were recommended, and delivery was 
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imposed only by reversed diastolic flow of the umbilical 
artery associated with an abnormal biophysical profile. 
Prolonged labor and fetal death 
Conventionally, labor abnormalities are described as 
protraction disorders or arrest disorders. An abnormally 
long active phase is called protracted, and an abnormally 
long latent phase is described as prolonged [23]. Regarding 
effects on the mother, these disorders are associated with 
an increased risk of postpartum hemorrhage, operative 
vaginal delivery, caesarean delivery, third or fourth degree 
perineal lacerations, and chorioamniotitis [24, 25]. As for 
the neonate, a protracted first stage of labor has not been 
associated with an increased risk of perinatal mortality and 
morbidity, whereas a prolonged second stage of labor has 
been associated with mortality and neonatal morbidity that 
can includes sepsis, seizures, and hypoxic-ischemic 
encephalopathy [26,27]. Usually, a prolonged second 
phase of labor is associated with fetal macrosomia or 
persistent malposition, thus increasing the risk of perinatal 
mortality and morbidity. The duration of the second phase 
is considered prolonged if a nulliparous woman has pushed 
for three hours or a multiparous woman has pushed for two 
hours, in the absence of epidural anesthesia, with a 
minimum or absent progression [28].  
Augmentation with oxytocin is indicated after 60-90 
minutes of pushing if birth progression is minimal or 
absent, and the uterine contractions have a frequency of 
less than 1 to 3 minutes, considering the fact that the main 
causes of prolonged second phase are macrosomia, a small 
maternal pelvis, and malposition or malpresentation, but 
not hypocontractility specifically during the first phase of 
labor. Extending these intervals is allowed only if a safe 
vaginal delivery is achievable from an obstetrical point of 
view, assessed by careful weighing of the risks and benefits 
that take into account obstetrical history, clinical 
pelvimetry, maternal height and weight, fetal position, 
surgical history, estimated fetal weight, fetal heart rate, and 
the patient’s consent after understanding the risks of 
prolonging labor [29-32].  
Interventions have been aimed at preventing the 
prolongation of labor, such as delayed pushing, changed 
maternal position, and pelvic floor muscle exercises.  None 
of these interventions appears to affect the length of the 
second phase [18, 33]. 
Pathology and intrauterine fetal death 
Ultrasonic examination of the placenta and the 
umbilical cord is essential for appropriate pregnancy 
monitoring. Multiple findings on sonographic examination 
can be related to adverse perinatal outcomes, including 
intrauterine fetal death. Here we discuss the particular 
ultrasound aspects of the umbilical cord and the placenta, 
along with their association with poor perinatal prognosis. 
1. Single umbilical artery - This diagnosis is based on the 
visualization of a single vessel around the fetal bladder, 
occurring in about 0.5% of pregnancies. This characteristic 
has been associated with maternal diabetes, smoking, and 
seizure disorders [34, 35]. The outcome of such cases is 
influenced by the associated conditions. Single umbilical 
artery without other anomalies does not demonstrate a 
statistically significant increase in fetal, neonatal, and 
infant death [20], but results in an increased risk when 
associated with anatomical and chromosomal anomalies. 
Recommended antepartum fetal monitoring, in the absence 
of other associated conditions, involves following fetal 
growth every 4-6 weeks, as there is a significant 
association between single umbilical artery and 
intrauterine growth restriction. A postnatal renal screening 
of infants should also be considered if the kidneys were 
poorly visualized on prenatal ultrasound [36, 37]. 
2. Hypoplasia of one umbilical artery may occasionally 
be diagnosed during ultrasound screening. There is no 
standard definition for the disparity between the sizes of 
the umbilical arteries. This condition has a higher 
prevalence in the high-risk population, and thus screening 
for other fetal anomalies should be performed. 
3. Aneurysm and varix of the umbilical cord have a low 
incidence, but they are also highly associated with fetal 
demise through rupture, intra-amniotic hemorrhage, and 
fetal exsanguination [21, 38]. If this abnormality is 
diagnosed prenatally, frequent fetal monitoring with non-
stress testing, ultrasound, and delivery after lung 
maturation are indicated [22, 23]. 
4. Velamentous cord insertion has a prevalence of 1% in 
singleton pregnancies, and it can be diagnosed through 
prenatal ultrasound examination by observing the 
umbilical cord insertion several centimeters from the 
placenta at the point where the umbilical vessels divide 
[39]. Fetal death can occur when fetal membranes rupture, 
which can lead to the rupture of the umbilical vessels, 
especially in the case of vasa previa [25, 40]. Considering 
these complications, if the ultrasound examination 
suggests velamentous cord insertion, a detailed ultrasound 
screening is required for the evaluation of coexisting vasa 
previa. Moreover, serial assessment of fetal growth, 
weekly non-stress testing after 36 weeks of gestation, and 
delivery at 40 weeks of gestation are also recommended. 
Specifically, these cases require continuous intrapartum 
fetal heart monitoring [41-43]. 
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5. True knot in the cord is associated with a high risk of 
fetal demise if the knot is tight or multiple [44, 45]. These 
pregnancies require close monitoring particularly in the 
last trimester, with serial ultrasound examinations that 
include Doppler evaluation, assessment of fetal growth, 
determining amniotic fluid index, biophysical profile 
scoring, and non-stress testing. 
6. Abruptio placentae affects about 1% of pregnancies, 
with the sensitivity of a prenatal ultrasound for this 
condition at only 25-60% [27, 46].  Chronic abruption is 
associated with a high risk for fetal growth restriction and 
all the consequences of this pathology, whereas acute 
abruption has a perinatal mortality of 3 to 12%, with more 
that 50% of these cases ending in stillbirth [47]. The 
diagnosis is mainly clinical, and the details of management 
include continuous fetal monitoring, secure intravenous 
access, monitoring the maternal hemodynamic status, and 
evaluating for coagulopathy [48, 49]. Subsequent medical 
decisions will depend on fetal and maternal status. 
Immediate delivery is recommended if the fetal heart rate 
pattern is non-reassuring or ominous. If the mother and the 
fetus are stable, but an abruption placenta is suspected, 
delivery is suggested for pregnancies after 34 weeks of 
gestation, as the benefits of delivery at this time surpass the 
risks. Because the risk of recurrence of this pathology (3-
15%) is common, a subsequent pregnancy for the patient 
should be considered a high-risk pregnancy. 
7. Placenta previa is associated with a 3-5 times 
increased risk of preterm birth [50, 51]; thus perinatal and 
neonatal morbidity and mortality are directly related to 
prematurity complications. In order to reduce neonatal 
morbidity and mortality rates, the administration of 
antenatal corticosteroids before 34 weeks of gestation is 
recommended for all placenta previa cases, and planned 
late preterm cesarean delivery should be considered. 
Several characteristics appear predictive of antepartum 
bleeding, including a cervical length less than 3 
centimeters, and a decrease in cervical length in the last 
trimester, as well as a thick placental edge with echo free 
space over the internal os [52]. 
Post-term pregnancy 
A post-term pregnancy may be associated with 
continued fetal growth with a subsequent birth of a large 
fetus, or a poorly functional placenta, resulting in fetal 
growth restriction and a small malnourished fetus for the 
gestational age [53]. A recent study [54] regarding the 
incidence of stillbirths in post-term pregnancies has 
indicated a twofold increase compared to term pregnancies. 
Factors that increase perinatal mortality incidence are feto-
placental insufficiency, asphyxia, intrauterine infection, 
primigravidity, and older maternal age [55]. For singleton, 
cephalic, uncomplicated pregnancies, the induction of 
labor at 41 weeks gestation, irrespective of the cervical 
status, is recommended in the context of a well predefined 
gestational age and a reassuring fetal assessment. This 
approach offers a 70% reduction in perinatal mortality and 
stillbirth [56]. Each decision must be adapted to the 
individual case, with the maternal perception of decreased 
fetal movement considered a marker for increased risk of 
fetal death [57].   
Gestational diabetes  
Pregnancies involving gestational diabetes require 
monitoring and treatment of the conditions associated with 
glucose impairment. The risk of stillbirth associated with 
gestational diabetes is higher than in the general 
population, and it is primarily related to poor glycemic 
control [58]. The presence of polyhydramnios appears to 
be an important marker for an increased stillbirth risk in all 
non-anomalous pregnancies with or without gestational 
diabetes [59]. Good glycemic control is the essential point 
in the management of these cases. Antenatal fetal testing 
includes non-stress testing twice a week and ultrasound 
examination of the amniotic fluid beginning at 32 weeks of 
gestation for all women with a poor glycemic control or 
treatment with insulin or oral anti-hyperglycemic drugs. 
Optimal timing of delivery for pregnancies with gestational 
diabetes may help avoid possible complications, including 
stillbirth. After discussing the risks and benefits with the 
patient, a recommended approach is to induce labor for 
euglycemic women after 39 weeks gestation, and for 
women with medically controlled gestational diabetes at 39 
weeks gestation. For women with poor glycemic control, 
delivery at 37+0 - 38+6 weeks gestation is considered 
reasonable [38, 60]. 
Infections 
Infection is responsible for one half of stillbirths in 
developing countries and 10 to 25% in developed countries 
[61, 62]. The effect is mediated through severe systemic 
maternal illness, placental infection, and placental 
dysfunction, or through fetal systemic illness. Most cases 
cause premature birth due to preterm premature rupture of 
membranes. Trans-placental infection is caused mostly by 
viral pathogens and less frequently by bacteria, fungi, 
spirochetes, and protozoa. Fetal death due to infection is 
not common, even though almost all systemic infections 
that occur during pregnancy can cause placental infection. 
In endemic areas, malaria is a common cause of stillbirth. 
Well-known maternal infections that can lead to fetal 
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demise include cytomegalovirus, parvovirus, 
toxoplasmosis, listeria, and herpes simplex virus [63, 64]. 
Asymptomatic maternal vaginal infections are highly 
frequent, therefore, successive screening for urinary and 
genital infection during pregnancy is mandatory.  
It is important to mention infection with Group B 
streptococcus, which is a frequent cause of asymptomatic 
bacteriuria, as well as urinary tract infection and upper 
genital tract infection. Data from Centers for Disease 
Control and Prevention (USA) indicate a 0.12 per 1000 live 
births rate of infection with Group B streptococcus, which 
can lead to adverse outcomes such as neonatal infections, 
fetal death, neonatal death, and pregnancy loss for 50% of 
cases [52, 65]. 
Conclusions 
Based on this review, we formulated a prevention 
strategy for stillbirth that involves 10 basic interventions: 
1. Periconceptional supplementation with folic acid 
2. Prevention of malaria in endemic areas 
3. Screening for and treatment of syphilis 
4. Detection, prevention, and treatment of hypertensive 
disorders of pregnancy 
5. Detection and appropriate management of gestational 
diabetes 
6. Screening, monitoring, and management of 
pregnancies complicated with intrauterine growth 
restriction 
7. Identification and induction of post-term pregnancies 
8. Delivery in a specialized unit assisted by a skilled birth 
attendant 
9. Capacity for possible basic emergency obstetric care 
10. Capacity for possible comprehensive emergency 
obstetric care.  
Although no research trials have demonstrated an 
effective method for reducing stillbirth rates in the general 
population, the above strategies are generally applicable 
and important. By identifying conditions that increase the 
risk of stillbirth, its occurrence can be reduced through an 
appropriate obstetrical approach, as management with 
suboptimal care is responsible for 10 to 60% of perinatal 
deaths. Interventions to lower modifiable risk factors, the 
prevention of obesity or encouragement of weight 
reduction, the avoidance of pregnancies at extreme 
maternal age, smoking cessation, and alcohol and 
recreational drug abstinence could reduce the number of 
stillbirths. Antenatal fetal monitoring that identifies fetuses 
with intrauterine growth restriction or fetuses with non-
reassuring status are key strategies for stillbirth reduction, 
as they lead to increased monitoring and care. As an 
example, an audit from Northern Ireland reported that the 
most common error leading to intrauterine fetal death was 
failure in diagnosing and appropriately managing cases 
with intrauterine growth restriction.  
On a final note, as a practitioner, it may be difficult to 
choose an appropriate way to react to and communicate 
with the parents after the birth of a stillborn child. Several 
key points described in this article may offer grieving 
parents explanation of the situation, which may support 
them during their bereavement. 
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